Advertisement

Picture Berlin Partner Hotspot for Startups 650x80px
Document › Details

Financieele Dagblad (FD.nl) [de Lange, Rob]. (7/19/19). "News: Codename »Eagles«: the Making of Galapagos’ Unprecendeted Billion-Dollar Pact with Gilead".

Organisations Organisation Galapagos N.V. (Euronext + Nasdaq: GLPG)
  Group Galapagos (Group)
  Organisation 2 Gilead Sciences Inc. (Nasdaq: GILD)
  Group Gilead Sciences (Group)
Products Product filgotinib (GLPG0634)
  Product 2 drug discovery services
Index terms Index term Gilead–Galapagos: drug research + development, 201907–202906 strategic 10y collab $3.9b upfront + $1.1b equity investment + milestones
  Index term 2 Ablynx–Sanofi: investment, 201801–201806 acquisition recommended cash tender offer €3.9b with €45/share
Persons Person van de Stolpe, Onno (Galapagos 1999– CEO + Founder before IntroGene BV + Molecular Probes Europe BV)
  Person 2 Wigerinck, Piet (Galapagos 201304 CSO before SVP Developm before Tibotec)
     


   
Record changed: 2019-08-07

Advertisement

Picture EBD Group Global Partnering Four Events One Price 650x80

More documents for Galapagos (Group)


To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Advertisement

Picture EBD Group Global Partnering Four Events One Price 650x80




» top